Tessera Technologies Inc. (NASDAQ: TSRA) will replace Financial Federal Corp. (NYSE: FIF) in the S&P SmallCap 600 index after the close of trading on Thursday, February 18. Financial Federal is being acquired by S&P 500 constituent Peoples United Financial Inc. (NASDAQ: PBCT) in a deal expected to close on or about that date, pending final approvals.@w
RealNetworks, Inc. (NASDAQ: RNWK) and MTV Networks, a division of Viacom International, Inc. (NYSE: VIA-A and VIA-B), today announced plans to restructure their digital music service joint venture, Rhapsody America LLC, into a newly formed corporation that will operate independently from its parent companies. RealNetworks, currently the majority owner and operator of Rhapsody, and Viacom will restructure their ownership and rights in the joint venture to provide the necessary intellectual property rights to launch the new company as an independent entity. RealNetworks will also contribute operating capital as part of the transaction. Under the terms of the restructuring, which is expected to close at the end of the first quarter, RealNetworks will no longer have operating control over the venture, and Rhapsody will have no single majority owner.
"Separating Rhapsody into its own independent company is a significant first step in making RealNetworks a more focused and profitable company," said Robert Kimball, president and acting CEO for RealNetworks. "Rhapsody will be the largest pure play digital music service in the market. We have provided Rhapsody with the right team, and financial and intellectual property assets to succeed in the competitive market for digital music."
In a Form 8-K, Watts Water Technologies, Inc. (NYSE: WTS) disclosed that on February 8, 2010, the Board approved a restructuring program with respect to the Company’s operating facilities in France. The restructuring program is expected to include the shutdown of three facilities, including two manufacturing sites and one distribution center.
The program is expected to include pre-tax charges totaling approximately $12.5 million, including costs for severance, relocation, clean-up and certain asset write-downs, and result in the elimination of approximately 95 positions. Total net after-tax charges for this restructuring program are expected to be approximately $8.3 million ($1.1 million in non-cash charges), with costs being incurred through 2011. The Company expects to spend approximately $6.6 million in capital expenditures to consolidate operations. Annual cash savings, net of tax, are estimated to be $3.9 million, which the Company expects to fully realize by 2012. The Company recorded after-tax charges of approximately $3.0 million, or ($0.08) per share, in the fourth quarter of 2009 for severance and other costs related to this program.
Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) announced that the first patent covering the composition and method of use of Intermezzo (zolpidem tartrate sublingual tablet), the lead Transcept product candidate, has been issued by the United States Patent and Trademark Office. Transcept announced the issuance of a Notice of Allowance for claims under the application for this patent, U.S. Patent Application Serial No. 11/060,641, on December 14, 2009. The newly issued patent, U.S. Patent No. 7,658,945, titled "Compositions for Delivering Hypnotic Agents Across the Oral Mucosa and Methods of Use Thereof," will expire no earlier than February 2025.
Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in neuroscience.
[SM]
AAR CORP. (NYSE: AIR) today commented that results for the third quarter ending February 28, 2010, will be unfavorably impacted by approximately $0.10 diluted earnings per share as a result of Mesa Air Group, Inc.'s (Mesa) January 5, 2010 Chapter 11 filing under the United States Bankruptcy Code. The impact mostly reflects the Company's estimated loss on pre-petition trade accounts receivables and the reduction in the carrying value of other contract related assets.
Sales to Mesa prior to the reorganization filing approximated $70 million per year. Based upon the Company's current understanding of Mesa's requirements, the Company expects annual sales to Mesa to now approximate $45 million.
Commenting on the outlook for the third quarter, David P. Storch, Chairman and Chief Executive Officer of AAR CORP., said, "We have not yet seen the uptick in sales to commercial customers in January that we had expected. However, our defense business remains strong and after excluding the unfavorable impact of Mesa, we expect to achieve modest sequential earnings per share improvement in our Fiscal 2010 third quarter results. We also expect continued strong cash flow from operations in our third quarter."
More Corporate News
View Older Stories-
AspenBio Pharma (APPY) Reports Results from Interim Analysis for Ongoing Trial of AppyScore
-
TheStreet.com (TSCM) Regains NASDAQ Compliance
-
S&P Lowers Pinnacle Entertainment (PNK) Outlook from Stable to Negative
-
AeroVironment (AVAV) Awarded $17.1M Army Contract for Raven Unmanned Aircraft System
-
Continental (CAL) to Suspend All 400 Flights at Newark Tomorrow
-
Suncor Energy (SU) Responds to Fire at its Oil Sands Upgrader
-
Google (GOOG) Tackles Social Media With "Buzz"
-
NV Energy (NVE), Pattern Energy Enter 20-Year Power Purchase Agreement for First Utility-Scale Wind Project in Nevada
-
Highlights From PHM's Q4 Conference Call: Expanded Opportunities & Cost Savings From Acquisition of Centex
-
Dendreon (DNDN) CEO Says Provenge Salesforce Will Be 125 People, Sees Full Manufacturing Ability by Mid-2011
-
IBM (IBM) Signs 5-Year Remote Managed Services Agreement with Sandhar Technologies
-
Google Unveils 'Buzz' Social Sharing Tool
-
Semiconductor Manufacturing Int (SMI) Confirms Seeking Alternatives for Company; No Definite Decision Made
-
Highlights From KO's Q4 Conference Call: Continued Solid Growth Globally in Several Segments
-
Toyota's (TM) Hearing in House on Recalls Moved to Feb. 24
-
Marathon Oil (MRO) Sells 20% Undivided Interest in Angola Block 32
-
GMAC Could Sell Rescap's UK Continental Europe Operations, 'Domestic Mortgage-Related Assets'
-
Highlights From HIG's Q4 Conference Call: Q4 Represented a Return to Profitability; Guides In-line for FY10
-
Lloyds (LYG) to Close Retail Banking Unit in Ireland; 750 Employees to be Affected
-
Delta (DAL) Canceled 375 Flights Today, 'Several Hundred' for Tomorrow Due to Winter Storm
-
Highlights From ERTS's Q3 Conference Call: Releasing Several New Titles, But Guides Below Street Consensus
-
General Dynamics (GD) Wins $253M Awarded from U.S. Army for Stryker Family Support
-
Airline Stocks Taking-Off as UAL Reports Strong Monthly Traffic Results; Investors Shrug at Flight Delays (UAUA, DAL, LUV, AMR, more)
-
Converted Organics (COIN) Ships Re-Order to Home Depot
-
S&P Lowers BofA (BAC) Credit Outlook from Stable to Negative
-
GameStop (GME) Shares Tumbling Amid Credit Suisse Downgrade, EA Earnings
-
Penson Worldwide's (PNSN) Securities Clearing Unit Signs Long-Term Agreement with TradeKing
-
Unit Corp (UNT) Updates on 2009 Proved Reserves and 2010 Corporate Info
-
Annaly Capital (NLY) Prices Offering of $500M in 4% Convertible Senior Notes
-
Noble (NE) Schedules Annual Meeting; Announces 0.52 CHF Quarterly Dividend
-
Novartis (NVS) Gains Rights to Develop and Distribute Debio 025; Currently in Phase IIb
-
Dynavax Tech (DVAX) Initiates HEPLISAV Phase 3
-
Cerus Corp. (CERS) Enters Into Agreement with EFS for INTERCEPT Blood System Development
-
Sequenom (SQNM) Gets Rights to Develop and Commercialize to Predict Genetic Predisposition for Macular AMD
-
Volcano (VOLC) Receives 501(k) Clearance to Market Eagle Eye Platinum Digital IVUS Catheter
-
L-1 Identity (ID) Awarded $33.7M Contract to Provide Secure Driver's Licenses in Kentucky
-
Chelsea Therapeutics (CHTP) Annoucnes Updates to NOH Phase III Registration Program; Preliminary U.S. FDA Approval for Northera
-
Cell Therapeutics (CTIC) Pixantrone NDA Meeting Delayed by U.S. FDA Due to Inclement Waether
-
Post Properties (PPS) Announces 4M Share At-the-Market Offering
-
Euro Tech Holdings (CLWT) Subsidiary Awarded $3.8M Wastewater Treatment System Installation Contract
-
XOMA (XOMA) Begins Enrollment for XOMA 052 Phase 2b
-
Delcath Systems (DCTH) Signs Partner to Distribute PHP System in Taiwan
-
OSI Systems (OSIS) Body Scanners to Be Deployed at Heathrow and Manchester Airports
-
Heckmann (HEK) and Energy Transfer Ptnrs (ETP) to Collaborate in Haynesville and Marcellus Ops
-
Cowen Group (COWN) to Integrate Businesses to Streamline Operations
-
Acacia Research (ACTG) Subsidiary Enters into Patent Settlement Agreement
-
Cynosure (CYNO) Announces Settlement of Patent Infringement Lawsuit Against CoolTouch
-
AstraZeneca (AZN) Gets Additional Approval from U.S. FDA for CRESTOR
-
InterOil (IOC) Announces $4.5M Purchase of Second Rig
-
Delcath Systems (DCTH) Signs First Research, Distribution, Sales & Marketing Agreement in Asia
